The global Spirometer Market is witnessing significant growth as the increasing prevalence of respiratory disorders, rising demand for early diagnosis, and growing adoption of pulmonary function testing create strong demand for advanced respiratory diagnostic devices. Spirometers are widely used to assess lung function and diagnose conditions such as chronic obstructive pulmonary disease (COPD), asthma, and other respiratory disorders. The growing adoption of portable, connected, handheld, and home-use spirometers is further supporting market expansion.
According to Fortune Business Insights, the global Spirometer Market was valued at USD 815.6 million in 2025 and is projected to grow from USD 892.9 million in 2026 to USD 1,675.2 million by 2034, exhibiting a CAGR of 8.2% during 2026–2034.
Spirometer Market Growth Drivers
Rising Prevalence of Respiratory Disorders
The growing burden of chronic respiratory diseases is encouraging hospitals, diagnostic centers, primary care facilities, and other healthcare providers to adopt pulmonary function testing technologies. According to the World Health Organization, an estimated 363 million people were affected by asthma globally in 2023, highlighting the significant demand for respiratory diagnostic solutions.
Increasing Adoption of Portable and Connected Spirometers
The increasing availability of portable, handheld, wireless, app-connected, and home-use spirometers is another important factor supporting market growth.
Advanced spirometry systems can connect with mobile applications, cloud platforms, remote patient monitoring systems, and electronic medical records. These technologies improve accessibility, support remote monitoring, and help healthcare professionals track changes in lung function over time.
Spirometer Market Trends
Shift Toward Remote and Home-Based Spirometry
The transition from conventional clinic-based respiratory testing toward remote and home-based monitoring is emerging as a significant trend in the Spirometer Market. Home-based spirometers allow patients to measure important lung-function parameters outside traditional healthcare facilities.
Integration of AI and Digital Technologies
Another significant trend is the integration of artificial intelligence, cloud connectivity, automated reporting, and digital health technologies into spirometry systems.
Manufacturers are increasingly developing systems that reduce operator dependency, improve test quality, simplify data interpretation, and support remote respiratory monitoring. These innovations are expanding the use of spirometers across hospitals, primary care facilities, homecare settings, pharmacies, occupational health programs, and clinical trials.
Spirometer Market Segmentation
By Product Type
Based on product type, the market is segmented into devices, software, and accessories & consumables.
The software segment is expected to grow at a CAGR of 8.4% during the forecast period, supported by increasing demand for connected systems, digital data management, remote monitoring, and advanced reporting capabilities.
By Type
The market is divided into volume measurement and peak flow meters.
The volume measurement segment dominated the market in 2025, supported by the growing prevalence of respiratory diseases, established spirometry standards, and widespread adoption of pulmonary function testing systems in hospitals and specialized respiratory clinics.
Meanwhile, the peak flow meters segment is projected to grow at a CAGR of 8.7% during 2026–2034, driven by their growing use in respiratory monitoring and asthma management.
By Application
Based on application, the market is segmented into chronic obstructive pulmonary disorder (COPD), asthma, and others.
The COPD segment accounted for 44.7% of the global market in 2025, making it the leading application segment. The growing prevalence of COPD and increasing adoption of spirometry for diagnosis and disease management are supporting segment growth.
The asthma segment is expected to grow at a CAGR of 7.8% during the forecast period as healthcare providers increasingly use spirometry and respiratory monitoring technologies for asthma assessment and management.
By End User
The market is divided into hospitals, diagnostic centers, homecare settings, physician/primary care offices or clinics, and other facilities.
The hospitals segment dominated the market in 2025 and is expected to account for 39.0% of the market in 2026. Increasing hospital numbers, the rising prevalence of respiratory diseases, and growing adoption of spirometers for pulmonary function testing are supporting segment expansion.
The diagnostic centers segment is projected to grow at a CAGR of 8.0% during the forecast period, supported by increasing demand for specialized respiratory testing services.
For detailed market insights, visit: https://www.fortunebusinessinsights.com/industry-reports/spirometers-market-100486
Spirometer Market Regional Outlook
North America
North America dominated the Spirometer Market with a 43.91% share in 2025. The regional market was valued at USD 358.2 million in 2025, supported by the growing asthma burden, pulmonary screening programs, healthcare expenditure, and technological advancements in spirometer products.
The U.S. represents the major market within North America. The U.S. market is estimated at approximately USD 345.5 million in 2026, accounting for around 38.7% of global revenues.
Europe
Europe is projected to grow at a CAGR of 7.7% during the forecast period and is expected to reach approximately USD 205.4 million in 2026. Increasing research and development activities and the introduction of innovative respiratory diagnostic devices are supporting regional market growth.
The U.K. market is estimated at approximately USD 36.0 million in 2026, while Germany is projected to reach approximately USD 37.8 million during the same year.
Asia-Pacific
Asia-Pacific is expected to reach approximately USD 217.6 million in 2026, making it the third-largest regional market. Expanding healthcare infrastructure, increasing adoption of spirometry testing, and the growing prevalence of respiratory diseases are supporting regional growth.
China is projected to generate approximately USD 59.9 million in 2026, while Japan is estimated at around USD 51.8 million. India's market is estimated at approximately USD 23.8 million in 2026, representing around 2.7% of global revenues.
Japan
Japan's Spirometer Market is estimated at approximately USD 51.8 million in 2026, accounting for around 5.8% of global revenues. The country's increasing prevalence of asthma and COPD, along with growing adoption of respiratory monitoring devices, is supporting market expansion.
Challenges Affecting the Spirometer Market
Data security and regulatory requirements for connected spirometers also represent challenges for manufacturers and healthcare providers. Connected devices increasingly use mobile applications, cloud platforms, Bluetooth connectivity, remote patient monitoring, and automated interpretation, creating additional cybersecurity, privacy, regulatory, and software-validation requirements.
Spirometer Market Opportunities
The expansion of healthcare infrastructure in developing countries is creating significant Spirometer Market opportunities. Many emerging economies continue to have limited access to spirometry despite the increasing burden of chronic respiratory diseases.
The increasing development of healthcare infrastructure in countries such as India is expected to create additional opportunities for spirometry manufacturers as access to respiratory testing expands.
Competitive Landscape
The Spirometer Market includes companies focusing on advanced respiratory diagnostic devices, connected spirometry systems, software platforms, portable devices, and home-based monitoring solutions. Key players identified in the market include ndd Medizintechnik AG, COSMED srl, MGC Diagnostics Corporation, Vitalograph, Chest M.I., Inc., Jaeger Medical GmbH, Ganshorn Medizin Electronic GmbH, Medical International Research S.p.A. (MIR), and Midmark Corporation.
Request Sample Report: https://www.fortunebusinessinsights.com/industry-reports/spirometers-market-100486
Future Outlook
The global Spirometer Market is expected to maintain strong growth through 2034 as the prevalence of respiratory diseases, demand for early diagnosis, healthcare infrastructure expansion, and adoption of digital respiratory monitoring technologies increase worldwide. The market is projected to rise from USD 892.9 million in 2026 to USD 1,675.2 million by 2034, registering a CAGR of 8.2% during the forecast period.
What’s Driving Japan’s Market? Discover the Latest Spirometer Market Insights